Search results
5-year relative survival rates for nasal cavity and paranasal sinus cancers. These numbers are based on people diagnosed with cancers of the nasal cavity or paranasal sinus between 2012 and 2018.
17 mar 2023 · Paranasal sinus and nasal cavity cancer treatment options may include surgery, radiation therapy, and chemotherapy. Treatment depends upon extent or stage of disease. Learn more in this expert-reviewed summary.
27 cze 2024 · Sinonasal carcinoma is still a rare tumor of the head and neck tumors with a substantial risk of local and distant recurrence. Surgical margins have been confirmed to be a cross-sectional negative prognostic factor. Adequate surgical treatment at the time of first diagnosis is important.
6 cze 2022 · The five-year survival rate for regional nasal cavity and paranasal sinus cancer is about 52 percent. Distant — The sinus cancer has spread to structures that are further away from the sinuses, such as the liver.
9 lut 2024 · For people diagnosed with nasal cavity or paranasal sinus cancer in the UK and Ireland: more than 70 out of 100 people (more than 70%) will survive their cancer for 1 year or more after diagnosis around 50 out of 100 people (around 50%) will survive their cancer for 5 years or more after they are diagnosed
Prognosis in cancer of the nasal cavity is determined by multiple factors including T stage, N stage, tumor grade, and tumor histologic type as well as age and sex. All of these factors need to be considered when treatment modalities and prognosis are determined for patients with newly diagnosed cancer of the nasal cavity.
If you have nasal cavity or paranasal sinus cancer, you may have questions about your prognosis. A prognosis is the doctor's best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors.
